Drug Delivery across Biological Barriers
The reprint is a collection of original articles and reviews in the field of modern drug delivery systems and strategies for efficient drug transport across various biological barriers, including the blood-brain barrier, mucosal and endothelial barriers, and cell membranes.
Saved in:
| Other Authors: | , |
|---|---|
| Format: | Electronic Book Chapter |
| Language: | English |
| Published: |
Basel
MDPI - Multidisciplinary Digital Publishing Institute
2023
|
| Subjects: | |
| Online Access: | DOAB: download the publication DOAB: description of the publication |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000naaaa2200000uu 4500 | ||
|---|---|---|---|
| 001 | doab_20_500_12854_128671 | ||
| 005 | 20231130 | ||
| 003 | oapen | ||
| 006 | m o d | ||
| 007 | cr|mn|---annan | ||
| 008 | 20231130s2023 xx |||||o ||| 0|eng d | ||
| 020 | |a books978-3-0365-9040-0 | ||
| 020 | |a 9783036590417 | ||
| 020 | |a 9783036590400 | ||
| 040 | |a oapen |c oapen | ||
| 024 | 7 | |a 10.3390/books978-3-0365-9040-0 |c doi | |
| 041 | 0 | |a eng | |
| 042 | |a dc | ||
| 072 | 7 | |a M |2 bicssc | |
| 072 | 7 | |a KNDP |2 bicssc | |
| 100 | 1 | |a Tennikova, Tatiana B. |4 edt | |
| 700 | 1 | |a Korzhikova-Vlakh, Evgenia G. |4 edt | |
| 700 | 1 | |a Tennikova, Tatiana B. |4 oth | |
| 700 | 1 | |a Korzhikova-Vlakh, Evgenia G. |4 oth | |
| 245 | 1 | 0 | |a Drug Delivery across Biological Barriers |
| 260 | |a Basel |b MDPI - Multidisciplinary Digital Publishing Institute |c 2023 | ||
| 300 | |a 1 electronic resource (202 p.) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
| 520 | |a The reprint is a collection of original articles and reviews in the field of modern drug delivery systems and strategies for efficient drug transport across various biological barriers, including the blood-brain barrier, mucosal and endothelial barriers, and cell membranes. | ||
| 540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |4 https://creativecommons.org/licenses/by/4.0/ | ||
| 546 | |a English | ||
| 650 | 7 | |a Medicine |2 bicssc | |
| 650 | 7 | |a Pharmaceutical industries |2 bicssc | |
| 653 | |a brain cancer | ||
| 653 | |a blood-brain barrier | ||
| 653 | |a drug delivery | ||
| 653 | |a FUS | ||
| 653 | |a CED | ||
| 653 | |a nanomedicine | ||
| 653 | |a chitosan | ||
| 653 | |a cytotoxicity | ||
| 653 | |a DNA | ||
| 653 | |a heparin | ||
| 653 | |a transfection | ||
| 653 | |a pH-sensitive | ||
| 653 | |a Parkinson disease | ||
| 653 | |a chromone | ||
| 653 | |a monoamine oxidase B inhibitor | ||
| 653 | |a PEGylated nanoparticles | ||
| 653 | |a intestinal and brain permeability | ||
| 653 | |a barrier model | ||
| 653 | |a nose-to-brain | ||
| 653 | |a primary cells | ||
| 653 | |a RPMI 2650 | ||
| 653 | |a olfactory epithelium | ||
| 653 | |a respiratory epithelium | ||
| 653 | |a liraglutide | ||
| 653 | |a GLP-1 analog | ||
| 653 | |a oral peptide delivery | ||
| 653 | |a enzymatic barrier | ||
| 653 | |a intestinal permeability | ||
| 653 | |a PLGA nanoparticles | ||
| 653 | |a Caco-2 cells | ||
| 653 | |a Franz cells | ||
| 653 | |a apparent permeability coefficient | ||
| 653 | |a amphiphilic polypeptides | ||
| 653 | |a self-assembly | ||
| 653 | |a nanoparticles | ||
| 653 | |a siRNA delivery | ||
| 653 | |a VEGF | ||
| 653 | |a gene silencing | ||
| 653 | |a adsorptive-mediated transcytosis | ||
| 653 | |a antibody fragments | ||
| 653 | |a blood-brain barrier | ||
| 653 | |a brain metastases | ||
| 653 | |a monoclonal antibodies | ||
| 653 | |a peptide shuttles | ||
| 653 | |a antioxidants | ||
| 653 | |a epidermal growth factor receptor | ||
| 653 | |a interleukins | ||
| 653 | |a irritation | ||
| 653 | |a metabolism response | ||
| 653 | |a N-acetyltransferase | ||
| 653 | |a small heat and shock protein beta 1 | ||
| 653 | |a nanomaterials | ||
| 653 | |a antivirals | ||
| 653 | |a biological barriers | ||
| 856 | 4 | 0 | |a www.oapen.org |u https://mdpi.com/books/pdfview/book/8133 |7 0 |z DOAB: download the publication |
| 856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/128671 |7 0 |z DOAB: description of the publication |